| Molecular targeting therapies for neuroblastoma: Progress and challenges A Zafar, W Wang, G Liu, X Wang, W Xian, F McKeon, J Foster, J Zhou, ... Medicinal research reviews 41 (2), 961-1021, 2021 | 227 | 2021 |
| Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor T Li, L Xu, R Zheng, X Wang, L Li, H Ji, Q Hu Phytomedicine 68, 153153, 2020 | 40 | 2020 |
| Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway T Li, R Zheng, L Xu, M Zhou, X Wang, Q Guo, H Ji, L Li Toxicology and Applied Pharmacology 408, 115248, 2020 | 12 | 2020 |
| Targeting MDM2 for neuroblastoma therapy: in vitro and in vivo anticancer activity and mechanism of action W Wang, X Wang, M Rajaei, JY Youn, A Zafar, H Deokar, JK Buolamwini, ... Cancers 12 (12), 3651, 2020 | 8 | 2020 |
| FIP200 Methylation by SETD2 Prevents Trim21-Induced Degradation and Preserves Autophagy Initiation Y Dai, W Luo, W Li, Z Chen, X Wang, J Chang Cells 11 (21), 3333, 2022 | 1 | 2022 |
| Deficient Lmna in fibroblasts: an emerging role of non-cardiomyocytes in DCM X Wang, W Luo, J Chang The journal of cardiovascular aging 2 (3), 2022 | | 2022 |
